1.1 	A bill for an act
1.2 	relating to health; removing the commissioner of health's authority to add 
1.3 	qualifying medical conditions or delivery forms of medical cannabis;amending 
1.4 	Minnesota Statutes 2014, sections 152.22, subdivisions 6, 14; 152.27, subdivision 
1.5 	2; repealing Laws 2014, chapter 311, section 20.
1.6 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.7 	Section 1. Minnesota Statutes 2014, section 152.22, subdivision 6, is amended to read:
1.8 		Subd. 6.Medical cannabis. "Medical cannabis" means any species of the genus 
1.9 	cannabis plant, or any mixture or preparation of them, including whole plant extracts 
1.10 	and resins, and is delivered in the form of:
1.11 	(1) liquid, including, but not limited to, oil;
1.12 	(2) pill; or
1.13 	(3) vaporized delivery method with use of liquid or oil but which does not require 
1.14 	the use of dried leaves or plant form; or.
1.15 	(4) any other method, excluding smoking, approved by the commissioner.

1.16 	Sec. 2. Minnesota Statutes 2014, section 152.22, subdivision 14, is amended to read:
1.17 		Subd. 14.Qualifying medical condition. "Qualifying medical condition" means a 
1.18 	diagnosis of any of the following conditions:
1.19 	(1) cancer, if the underlying condition or treatment produces one or more of the 
1.20 	following:
1.21 	(i) severe or chronic pain;
1.22 	(ii) nausea or severe vomiting; or
1.23 	(iii) cachexia or severe wasting;
1.24 	(2) glaucoma;
2.1 	(3) human immunodeficiency virus or acquired immune deficiency syndrome;
2.2 	(4) Tourette's syndrome;
2.3 	(5) amyotrophic lateral sclerosis;
2.4 	(6) seizures, including those characteristic of epilepsy;
2.5 	(7) severe and persistent muscle spasms, including those characteristic of multiple 
2.6 	sclerosis;
2.7 	(8) Crohn's disease; or
2.8 	(9) terminal illness, with a probable life expectancy of under one year, if the illness 
2.9 	or its treatment produces one or more of the following:
2.10 	(i) severe or chronic pain;
2.11 	(ii) nausea or severe vomiting; or
2.12 	(iii) cachexia or severe wasting; or.
2.13 	(10) any other medical condition or its treatment approved by the commissioner.

2.14 	Sec. 3. Minnesota Statutes 2014, section 152.27, subdivision 2, is amended to read:
2.15 		Subd. 2.Commissioner duties. (a) The commissioner shall:
2.16 	(1) give notice of the program to health care practitioners in the state who are 
2.17 	eligible to serve as health care practitioners and explain the purposes and requirements 
2.18 	of the program;
2.19 	(2) allow each health care practitioner who meets or agrees to meet the program's 
2.20 	requirements and who requests to participate, to be included in the registry program to 
2.21 	collect data for the patient registry;
2.22 	(3) provide explanatory information and assistance to each health care practitioner 
2.23 	in understanding the nature of therapeutic use of medical cannabis within program 
2.24 	requirements;
2.25 	(4) create and provide a certification to be used by a health care practitioner for the 
2.26 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
2.27 	condition and include in the certification an option for the practitioner to certify whether 
2.28 	the patient, in the health care practitioner's medical opinion, is developmentally or 
2.29 	physically disabled and, as a result of that disability, the patient is unable to self-administer 
2.30 	medication or acquire medical cannabis from a distribution facility;
2.31 	(5) supervise the participation of the health care practitioner in conducting patient 
2.32 	treatment and health records reporting in a manner that ensures stringent security and 
2.33 	record-keeping requirements and that prevents the unauthorized release of private data on 
2.34 	individuals as defined by section 13.02;
3.1 	(6) develop safety criteria for patients with a qualifying medical condition as a 
3.2 	requirement of the patient's participation in the program, to prevent the patient from 
3.3 	undertaking any task under the influence of medical cannabis that would constitute 
3.4 	negligence or professional malpractice on the part of the patient; and
3.5 	(7) conduct research and studies based on data from health records submitted to 
3.6 	the registry program and submit reports on intermediate or final research results to the 
3.7 	legislature and major scientific journals. The commissioner may contract with a third 
3.8 	party to complete the requirements of this clause. Any reports submitted must comply 
3.9 	with section 152.28, subdivision 2.
3.10 	(b) If the commissioner wishes to add a delivery method under section 152.22, 
3.11 	subdivision 6, or a qualifying medical condition under section 152.22, subdivision 14, the 
3.12 	commissioner must notify the chairs and ranking minority members of the legislative policy 
3.13 	committees having jurisdiction over health and public safety of the addition and the reasons 
3.14 	for its addition, including any written comments received by the commissioner from the 
3.15 	public and any guidance received from the task force on medical cannabis research, by 
3.16 	January 15 of the year in which the commissioner wishes to make the change. The change 
3.17 	shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

3.18 	Sec. 4.  REPEALER.
 3.19 	Laws 2014, chapter 311, section 20, is repealed.